Side-by-side comparison of AI visibility scores, market position, and capabilities
Marketer-first customer data platform that builds unified first-party profiles and enables direct audience activation across channels without engineering dependency.
BlueConic is a Boston-based customer data platform company that builds a marketer-accessible layer of unified customer profile data on top of existing enterprise data systems, enabling marketing teams to collect, unify, and activate first-party data without relying on engineering teams for every campaign and segmentation request. The platform's unified customer profiles consolidate behavioral data, transactional history, declared preferences, and demographic attributes into persistent profiles that update in real time as customers interact across web, mobile, email, and in-store touchpoints. BlueConic's Lifecycles feature allows marketers to build visual customer journey workflows that trigger personalization, offers, and communications based on profile attributes and behavioral triggers, enabling sophisticated lifecycle marketing without custom development. The platform emphasizes first-party data collection and activation at a time when third-party cookie deprecation has forced brands to invest more deeply in owned customer data relationships. BlueConic serves media companies, retailers, and financial services brands — including Hearst, ING, and Heineken — across North America and Europe. Founded in 2010 in the Netherlands and now headquartered in Boston, BlueConic raised over $45M from investors including Insight Partners and Battery Ventures, competing with Tealium, Segment, and Bloomreach in the marketer-facing CDP market.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.